Which aspects of aging can NAD+ actually reverse?
The strongest evidence from these studies points to improvements in metabolic and cardiovascular risk factors, not in physical performance or muscle function. In a randomized controlled trial of 30 overweight or obese adults aged 45 and older, taking a NAD+ precursor (MIB-626) for 28 days led to a significant drop in body weight (1.9 kg more than placebo), total cholesterol (down 26.9 mg/dL), LDL cholesterol (down 18.7 mg/dL), and diastolic blood pressure (down 7.0 mmHg) [1]. These are the same markers that typically worsen with age and increase risk of heart disease and diabetes. However, the same study found no significant changes in muscle strength, muscle fatigability, aerobic capacity, or stair-climbing power [1] — meaning NAD+ did not reverse age-related declines in physical function over that short period.
In a more targeted setting, a 2026 study using a specialized nanoplatform to deliver NAD+ directly to aged bone cells in animals achieved dramatic results: the NAD+/NADH ratio increased 11.2-fold, ATP (cellular energy) production rose 3.25-fold, and bone volume fraction improved by 119% after four weeks [2]. This suggests NAD+ can reverse cellular aging in specific tissues when delivered effectively, even if whole-body physical performance is harder to change.
Who is most likely to see benefits from NAD+ supplementation?
The people who benefit most appear to be those whose NAD+ levels are already depleted due to age, metabolic conditions, or genetic disorders. A 2026 review highlights that NAD+ supplementation shows 'promising benefits' in rare premature-aging diseases where DNA repair is faulty and NAD+ is excessively consumed by overactive PARP enzymes [3]. In these conditions, boosting NAD+ improved DNA repair and mitochondrial function. Similarly, a 2023 review on ovarian aging notes that NAD+ levels decline as ovaries age, and supplementing with NAD+ precursors can 'substantially improve oocyte quality and alleviate ovarian aging' [5]. This aligns with the metabolic trial [1], where participants were overweight or obese — a group known to have lower NAD+ — and saw clear improvements in cholesterol and blood pressure.
Conversely, the same review [3] cautions that 'some studies show no observable advantages,' meaning healthy individuals with normal NAD+ levels may not experience noticeable anti-aging effects. The key factor is whether your NAD+ is depleted in the first place.
How does NAD+ work at the cellular level to reverse aging?
NAD+ acts as a critical fuel for two main anti-aging processes: DNA repair (via PARP enzymes) and mitochondrial energy production (via sirtuins). When DNA gets damaged — a hallmark of aging — PARP enzymes consume NAD+ to fix the breaks. If NAD+ runs low, repair stalls and damage accumulates. A 2022 study in mice showed that boosting NAD+ with nicotinamide riboside (NR) activated the sirtuin SIRT1, which in turn increased deacetylation of PGC-1α, a master regulator of mitochondrial biogenesis [4]. This restored mitochondrial function and protected the gut barrier from alcohol-induced damage. The same mechanism likely applies to aging: by keeping mitochondria healthy, NAD+ helps cells maintain energy and resist stress.
The bone regeneration study [2] provides direct evidence: the nanoplatform that boosted NAD+ also increased ATP production by 3.25-fold in aged stem cells, and reduced the proportion of senescent (aged) cells to just 21.2% after seven days. This shows that restoring NAD+ can literally reverse the senescent state in cells, making them behave younger again.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2022 to 2026, 2 from 2024 or later, 5 in Q1 journals, collectively cited 114 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 69 papers retrieved from a database of over 500 million.
Sources used in this answer
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study
In a 28-day randomized controlled trial of 30 overweight or obese adults aged 45+, the NAD+ precursor MIB-626 safely increased NAD levels and significantly reduced body weight (by 1.9 kg), LDL cholesterol (by 18.7 mg/dL), and diastolic blood pressure (by 7.0 mmHg), but did not improve muscle strength or aerobic capacity.
A sustained NAD+ supplementation-biosynthesis nanoplatform for metabolic restoration in aged bone regeneration.
A 2026 animal study using a nanoplatform for sustained NAD+ delivery to aged bone cells increased the NAD+/NADH ratio by 11.2-fold, boosted ATP production by 3.25-fold, reduced senescent cells to 21.2%, and improved bone volume fraction by 119% after four weeks.
Promising Results With NAD Supplementation in Rare Diseases With Premature Aging and DNA Damage
A 2026 review notes that NAD+ supplementation shows promising benefits in rare premature-aging diseases with DNA repair defects, improving DNA repair and mitochondrial function, but also acknowledges that some human studies show no observable advantages, highlighting the need to identify individuals with NAD+ depletion.
NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial Function
In a 2022 mouse and cell study, the NAD+ booster nicotinamide riboside (NR) protected the intestinal barrier from ethanol damage by activating SIRT1, increasing deacetylation of PGC-1α, and reversing mitochondrial dysfunction; these effects were lost when SIRT1 was knocked down.
Impact of NAD+ metabolism on ovarian aging
A 2023 review on ovarian aging states that NAD+ levels decline as ovaries age, and supplementation with NAD+ precursors can substantially improve oocyte quality and alleviate ovarian aging, offering promise for fertility in older women.